OraSure Addresses FDA Warning Letter on DNA Genotek

OraSure Technologies (Nasdaq: OSUR ) announced that its molecular collection systems subsidiary, DNA Genotek, received a warning letter from the U.S. Food and Drug Administration (FDA) which the FDA posted today on its website. The warning letter primarily focuses on DNA Genotek's response to two observations issued by the